Hexo details U.S. CBD plans as Q3 earnings miss estimates, stock slips
Cannabis company Hexo Corp. outlined its plans to enter eight U.S. states with CBD products in 2020 as it reported third-quarter earnings that fell short of expectations, sending its stock lower. Hexo chief executive Sebastien St.
Read more »